Effects of magnesium supplements on blood pressure, endothelial function and metabolic parameters in healthy young men with a family history of metabolic syndrome

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 11, 2014, Pages 1213-1220

  Cosaro, E ^a   Bonafini, S ^a   Montagnana, M ^a   Danese, E ^a   Trettene, M S ^a   Minuz, P ^a   Delva, P ^a   Fava, C ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Arterial stiffness; Blood pressure; Diabetes; Flow mediated dilatation; Magnesium; Metabolic syndrome; Positive family history

Indexed keywords

C REACTIVE PROTEIN; PLACEBO; PYROGLUTAMATE MAGNESIUM;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; URINALYSIS; YOUNG ADULT;

EID: 84909590098     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.05.010     Document Type: Article

References (30)

1. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120(16):1640-1645.
2. Barbagallo M., Dominguez L.J. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 2007, 458(1):40-47.
3. Guerrero-Romero F., Rodrguez-Morn M. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial. J Hum Hypertens 2009, 23(4).
4. Sontia B., Touyz R.M. Magnesium transport in hypertension. Pathophysiology 2007, 14(3-4):205-211.
5. Afsar B., Elsurer R. The relationship between magnesium and ambulatory blood pressure, augmentation index, pulse wave velocity, total peripheral resistance, and cardiac output in essential hypertensive patients. J Am Soc Hypertens 2014, 8(1):28-35.
6. Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev 2003, 24(2):47-66.
7. Larsson S.C., Wolk A. Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med 2007, 262(2):208-214.
8. Song Y., Ridker P.M., Manson J.E., Cook N.R., Buring J.E., Liu S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 2005, 28(6):1438-1444.
9. Bayturan O., Tuzcu E.M., Lavoie A., Hu T., Wolski K., Schoenhagen P., et al. The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. Arch Intern Med 2010, 170(5):478-484.
10. Pham P.C., Pham P.M., Pham S.V., Miller J.M., Pham P.T. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol 2007, 2(2):366-373.
11. Lima Mde L., Cruz T., Rodrigues L.E., Bomfim O., Melo J., Correia R., et al. Serum and intracellular magnesium deficiency in patients with metabolic syndrome-evidences for its relation to insulin resistance. Diabetes Res Clin Pract 2009, 83(2).
12. Rodriguez-Moran M., Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003, 26(4):1147-1152.
13. Lee S., Park H.K., Son S.P., Lee C.W., Kim I.J., Kim H.J. Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in normo-magnesemic nondiabetic overweight Korean adults. Nutr Metab Cardiovasc Dis 2009, 19(11):781-788.
14. Guerrero-Romero F., Tamez-Perez H.E., Gonzalez-Gonzalez G., Salinas-Martinez A.M., Montes-Villarreal J., Trevino-Ortiz J.H., et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab 2004, 30(3):253-258.
15. Minuz P., Fava C., Cominacini L. Oxidative stress, antioxidants, and vascular damage. Br J Clin Pharmacol 2006, 61(6):774-777.
16. Bianchini E., Bozec E., Gemignani V., Faita F., Giannarelli C., Ghiadoni L., et al. Assessment of carotid stiffness and intima-media thickness from ultrasound data: comparison between two methods. J Ultrasound Med 2010, 29(8):1169-1175.
17. Gemignani V., Bianchini E., Faita F., Giannarelli C., Plantinga Y., Ghiadoni L., et al. Ultrasound measurement of the brachial artery flow-mediated dilation without ECG gating. Ultrasound Med Biol 2008, 34(3):385-391.
18. Bianchini E., Bruno R.M., Corciu A.I., Faita F., Gemignani V., Ghiadoni L., et al. Assessment of carotid elasticity during exercise: a reproducibility study. Ultrasound Med Biol 2012, 38(2):223-230.
19. Millasseau S.C., Kelly R.P., Ritter J.M., Chowienczyk P.J. The vascular impact of aging and vasoactive drugs: comparison of two digital volume pulse measurements. Am J Hypertens 2003, 16(6).
20. Delva P., Pastori C., Montesi G., Degan M., Micciolo R., Paluani F., et al. Intralymphocyte free magnesium and calcium and insulin tolerance test in a group of essential hypertensive patients. Life Sci 1998, 63(16):1405-1415.
21. Dickinson H.O., Nicolson D.J., Campbell F., Cook J.V., Beyer F.R., Ford G.A., et al. Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst Rev 2006, 3.
22. He K., Liu K., Daviglus M.L., Morris S.J., Loria C.M., Van Horn L., et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 2006, 113(13).
23. Perk J., De B.G., Gohlke H., Graham I., Reiner Z., Verschuren M., et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012, 33(13):1635-1701.
24. Walker A.F., Marakis G., Christie S., Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res 2003, 16(3):183-191.
25. Hatzistavri L.S., Sarafidis P.A., Georgianos P.I., Tziolas I.M., Aroditis C.P., Zebekakis P.E., et al. Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension. Am J Hypertens 2009, 22(10):1070-1075.
26. Czernichow S., Vergnaud A.C., Galan P., Arnaud J., Favier A., Faure H., et al. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. Am J Clin Nutr 2009, 90(2):329-335.
27. Shechter M., Sharir M., Labrador M.J., Forrester J., Silver B., Bairey Merz C.N. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 2000, 102(19):2353-2358.
28. Van L.S., Marechal C., Verbeke F., Peeters P., Van B.W., Devuyst O., et al. The relation between hypomagnesaemia and vascular stiffness in renal transplant recipients. Nephrol Dial Transplant 2011, 26(7):2362-2369.
29. Resnick L.M., Militianu D., Cunnings A.J., Pipe J.G., Evelhoch J.L., Soulen R.L. Direct magnetic resonance determination of aortic distensibility in essential hypertension: relation to age, abdominal visceral fat, and in situ intracellular free magnesium. Hypertension 1997, 30(3 Pt 2):654-659.
30. Rogers D.T., Colon M., Gambala C., Wilkins I., Hibbard J.U. Effects of magnesium on central arterial compliance in preeclampsia. Am J Obstet Gynecol 2010, 202(5):448.